Midday Report: Applied Dna (APDN) Falls on July 25


Applied Dna Sciences Inc (NASDAQ: APDN) shares lost 7.22%, or $0.0549 per share, as on 11:41:23 est today. Since opening the day at $0.77, 155,113 shares of Applied Dna have been traded today and the stock has ranged between $0.77 and $0.70.  



This year the company has a YTD change of 81.09%.



Applied Dna anticipates its next earnings on 2022-08-11.



For technical charts, analysis, and more on Applied Dna visit the company profile.




About Applied Dna Sciences Inc

Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction (‘PCR’)-based manufacturing platform that allows for the large-scale production of specific DNA sequences. The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies. Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company’s deep expertise in DNA. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.



To get more information on Applied Dna Sciences Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Applied Dna Sciences Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.



Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer


Kagan: IBM Watson Health Fails, Becomes Merative After Acquisition
Population Boom Will Drive Metals and Minerals Prices
The Best Laid Plans of Mice and Men — Part III
Are Stocks Cheap Yet?



Read more here: Source link